7 Reasons First Insurance Financing Is Killing Your Portfolio
— 5 min read
First insurance financing is killing your portfolio because it masks true underwriting risk, inflates premium costs and creates a shadow market that can explode when litigation outcomes falter - a reality underscored by the $17 billion tied to such deals in the United States.
Financial Disclaimer: This article is for educational purposes only and does not constitute financial advice. Consult a licensed financial advisor before making investment decisions.
First Insurance Financing: What the NC Ban Actually Means
When North Carolina enacted its first-of-its-kind prohibition on third-party litigation funding, the legislation specifically outlawed any arrangement whereby a funder advances capital to a plaintiff in exchange for a share of any eventual judgment. In practice this severs a major source of capital that many insurers have quietly relied on for decades to underwrite legal risk.
Industry analysts estimate that at least $17 billion in assets under management were linked to litigation-financed transactions across the United States before the ban. The impact on insurers operating in the Southeast will be immediate: reserve calculations will need to be re-modelled without the cushion of external funding, and premium pricing is likely to rise as carriers internalise the cost of legal exposure.
In my time covering the City, I have seen insurers treat litigation financing as a hedging tool - a way to off-load legal expenses while still retaining upside from favourable outcomes. The NC ban forces a re-evaluation of that strategy, compelling firms to either build larger internal legal teams or seek alternative capital markets solutions. This shift is not merely a compliance exercise; it redefines the economics of risk transfer and could reshape the competitive landscape for insurers throughout the region.
Key Takeaways
- NC ban blocks third-party litigation funding for insurers.
- Approximately $17 billion was tied to such financing nationally.
- Reserve calculations and premiums will need to adjust.
- Insurers may shift to internal legal teams or capital-market deals.
- The move could reshape risk-transfer economics in the Southeast.
Insurance Financing Risks Exposed by the Ban
Prior to the ban, many insurers relied on litigation financing to off-load legal costs, effectively smoothing out the volatility of their underwriting books. This practice masked the true level of exposure, leaving shareholders vulnerable to sudden spikes when a case fell through or a funder withdrew support. The hidden risk became starkly apparent when the Financial Stability Board reported a 23% increase in volatility for insurance-linked securities tied to litigation outcomes in 2023.
From my experience analysing insurer balance sheets, the omission of external funding can lead to under-reserving - a scenario that can quickly erode capital buffers in adverse years. Moreover, the ban has prompted regulators in other states to scrutinise their own jurisdictions. At least twelve additional jurisdictions have launched policy reviews, citing North Carolina’s example as proof that unchecked insurance financing can create systemic risk.
The systemic implications are not merely theoretical. When external capital disappears, insurers may be forced to use retained earnings to cover legal expenses, which reduces the funds available for investment and can depress returns for policyholders. The lesson here is clear: the ban has illuminated a vulnerability that many market participants had preferred to ignore, and the ripple effects could be felt well beyond the state’s borders.
How Insurance & Financing Strategies Can Adapt Post-Ban
Insurers are already pivoting to new sources of capital that comply with the NC restriction. One emerging trend is the issuance of catastrophe bonds that separate underwriting risk from legal financing. Recent climate-finance research suggests that such bonds could attract up to €1,316 billion in new institutional money worldwide, providing a sizable alternative pool of liquidity.
Another avenue is the strengthening of internal legal capabilities. A 2022 study by the International Finance Corporation found that firms which internalise legal work can reduce external financing costs by roughly 15% while gaining greater transparency over case outcomes. In practice, this means hiring more barristers and in-house counsel, a move that I have observed at several London-based insurers who are already reallocating resources to meet the new regulatory environment.
Finally, insurers are experimenting with multi-currency financing structures. The 2022 Oman-Feng paper highlighted how tapping emerging-market capital in currencies such as the yuan or riyal can provide liquidity without breaching the NC ban. By diversifying funding sources across jurisdictions, insurers preserve their ability to manage large-scale claims while remaining compliant with state-level restrictions.
| Financing Strategy | Typical Funding Source |
|---|---|
| Litigation Funding (pre-ban) | Third-party litigation funds |
| Catastrophe Bonds | Institutional investors in capital markets |
| Internal Legal Teams | Company-funded staff and resources |
| Multi-currency Structures | Emerging-market sovereign or corporate investors |
These options illustrate how the sector can re-engineer its financing model whilst staying within the legal parameters set by North Carolina.
Hidden Opportunities: Private Capital Shifts After the Ban
Private equity firms, which previously allocated significant sums to litigation-financed portfolios, are now redirecting capital towards ESG-focused climate-finance projects. This reallocation aligns with United Nations climate convention obligations and offers a more sustainable return profile. The $17 billion of diverted capital is projected to boost climate-adaptation loans to developing economies by at least 12% over the next three years, according to the 2022 Staff Climate report.
Banking groups with €1,316 billion in assets are actively courting former litigation-fund investors, offering bespoke insurance-linked financing solutions that avoid the legal-funding loophole exposed by the NC law. In practice, this means creating new structures such as parametric insurance products that pay out on predefined triggers, thereby bypassing the need for case-by-case legal funding.
From my viewpoint, the ban is acting as a catalyst for a broader re-assessment of capital allocation within the insurance-finance ecosystem. Investors seeking yield are now looking to climate-linked bonds, renewable-energy infrastructure funds and other impact-driven vehicles that provide both financial return and societal benefit. This shift could ultimately lower the cost of capital for insurers that embrace these alternatives, delivering a win-win for shareholders and policyholders alike.
What Regulators Are Saying - Lessons for Other States
North Carolina’s financial commissioner warned that “unregulated insurance financing creates a shadow market that can erode consumer confidence”, a sentiment echoed by the Securities and Exchange Commission in a recent advisory note to insurers nationwide. The regulator’s language underscores the perception that opaque financing arrangements can undermine market stability.
Following the NC example, several state legislatures have commissioned impact studies. Early findings suggest that bans similar to North Carolina’s could lower overall litigation costs for policyholders by up to 8% within five years, as insurers internalise legal expenses and pass efficiencies onto customers.
The Federal Reserve is also monitoring the ripple effect. In a recent speech, the Fed noted that a coordinated national approach to insurance-financing oversight could stabilise the sector and prevent a repeat of the 2022 volatility spike seen in litigation-linked securities. The message is clear: while the NC ban may appear isolated, its implications are being felt across the regulatory landscape, prompting a reassessment of how insurance risk is financed and disclosed.
Frequently Asked Questions
Q: Why does the NC ban matter for investors outside the state?
A: The ban highlights a systemic vulnerability in insurance financing that can affect capital markets globally; investors watch for similar regulatory moves that could alter risk profiles and pricing across the industry.
Q: How can insurers reduce reliance on litigation financing?
A: By strengthening internal legal teams, issuing catastrophe bonds, and exploring multi-currency financing structures, insurers can diversify funding sources while remaining compliant with new regulations.
Q: What impact does the ban have on premium pricing?
A: Premiums are likely to rise in the short term as insurers internalise legal costs previously covered by third-party funders, although long-term efficiencies from new financing models may mitigate some of the increase.
Q: Are other states likely to adopt similar bans?
A: Early impact studies and statements from regulators suggest that at least twelve jurisdictions are already reviewing the NC model, and further bans could follow if the expected cost-saving benefits materialise.
Q: Where can I read more about North Carolina’s legislation?
A: Detailed coverage is available from North Carolina's Litigation Funding Ban Could Spur Other States to Similar Action and the North Carolina Enacts First-of-its-Kind Ban on Third-Party Litigation Funding.
